Karyopharm Therapeutics | KPTI - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Abbott USD 2.43B 844M 2026-03
Amgen USD 5.8B 1.25B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Incyte USD 778.57M 410.6M 2026-06
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Takeda JPY 369.75B 5.29B 2026-09
Tectonic Therapeutic USD -21.18M 365K 2025-12
TG Therapeutics USD 26.9M 1.21M 2026-06
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Xencor USD 25.1M 59.73M 2026-09